What is the projected market valuation for the Breast Cancer Core Needle Biopsy Market in 2035?

The projected market valuation for the Breast Cancer Core Needle Biopsy Market in 2035 is 0.7024 USD Billion. Read More

What was the market valuation for the Breast Cancer Core Needle Biopsy Market in 2024?

The market valuation for the Breast Cancer Core Needle Biopsy Market in 2024 was 0.4 USD Billion. Read More

What is the expected CAGR for the Breast Cancer Core Needle Biopsy Market from 2025 to 2035?

The expected CAGR for the Breast Cancer Core Needle Biopsy Market during the forecast period 2025 - 2035 is 5.25%. Read More

Which companies are considered key players in the Breast Cancer Core Needle Biopsy Market?

Key players in the Breast Cancer Core Needle Biopsy Market include Hologic, BD, Siemens Healthineers, GE Healthcare, Philips, Canon Medical Systems, Fujifilm, Medtronic, and Stryker. Read More

What segment of the Breast Cancer Core Needle Biopsy Market had the highest valuation in 2024?

In 2024, the Target Tissue segment for Breast Cancer had the highest valuation at 0.2 USD Billion. Read More

How does the valuation of the 14-Gauge needle segment compare to the 20-Gauge segment in 2024?

In 2024, the 14-Gauge needle segment was valued at 0.1 USD Billion, whereas the 20-Gauge segment was valued at 0.05 USD Billion. Read More

What is the projected growth for the Ultrasound-Guided modality segment by 2035?

The Ultrasound-Guided modality segment is projected to grow from 0.16 USD Billion in 2024 to approximately 0.2816 USD Billion by 2035. Read More

What is the expected market performance for outpatient procedures in the Breast Cancer Core Needle Biopsy Market?

The outpatient procedure segment is expected to grow from 0.24 USD Billion in 2024 to around 0.4224 USD Billion by 2035. Read More

Which biopsy device type is anticipated to show significant growth in the coming years?

The Vacuum-Assisted biopsy device type is anticipated to show significant growth, increasing from 0.16 USD Billion in 2024 to about 0.2816 USD Billion by 2035. Read More

What trends are influencing the Breast Cancer Core Needle Biopsy Market in 2025?

Trends influencing the Breast Cancer Core Needle Biopsy Market in 2025 include advancements in technology and increasing awareness of early detection. Read More

Breast Cancer Core Needle Biopsy Market

ID: MRFR/HC/27391-HCR

128 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Breast Cancer Core Needle Biopsy Market Research Report By Target Tissue (Breast, Prostate, Lung, Liver, Kidney), By Needle Size (14-Gauge, 16-Gauge, 18-Gauge, 20-Gauge, 22-Gauge), By Modality (Ultrasound-Guided, Stereotactic, Other), By Procedure Type (Outpatient, Inpatient), By Biopsy Device Type (Vacuum-Assisted, Spring-Loaded, Gravity-Fed) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Breast Cancer Core Needle Biopsy Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Target Tissue (USD Billion)
  1. 4.1.1 Breast
  2. 4.1.2 Prostate
  3. 4.1.3 Lung
  4. 4.1.4 Liver
  5. 4.1.5 Kidney
2. 4.2 Healthcare, BY Needle Size (USD Billion)
  1. 4.2.1 14-Gauge
  2. 4.2.2 16-Gauge
  3. 4.2.3 18-Gauge
  4. 4.2.4 20-Gauge
  5. 4.2.5 22-Gauge
3. 4.3 Healthcare, BY Modality (USD Billion)
  1. 4.3.1 Ultrasound-Guided
  2. 4.3.2 Stereotactic
  3. 4.3.3 Other
4. 4.4 Healthcare, BY Procedure Type (USD Billion)
  1. 4.4.1 Outpatient
  2. 4.4.2 Inpatient
5. 4.5 Healthcare, BY Biopsy Device Type (USD Billion)
  1. 4.5.1 Vacuum-Assisted
  2. 4.5.2 Spring-Loaded
  3. 4.5.3 Gravity-Fed
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Hologic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 BD (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GE Healthcare (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Philips (NL)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Canon Medical Systems (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Fujifilm (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Medtronic (IE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Stryker (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TARGET TISSUE
4. 6.4 US MARKET ANALYSIS BY NEEDLE SIZE
5. 6.5 US MARKET ANALYSIS BY MODALITY
6. 6.6 US MARKET ANALYSIS BY PROCEDURE TYPE
7. 6.7 US MARKET ANALYSIS BY BIOPSY DEVICE TYPE
8. 6.8 CANADA MARKET ANALYSIS BY TARGET TISSUE
9. 6.9 CANADA MARKET ANALYSIS BY NEEDLE SIZE
10. 6.10 CANADA MARKET ANALYSIS BY MODALITY
11. 6.11 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
12. 6.12 CANADA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY TARGET TISSUE
15. 6.15 GERMANY MARKET ANALYSIS BY NEEDLE SIZE
16. 6.16 GERMANY MARKET ANALYSIS BY MODALITY
17. 6.17 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
18. 6.18 GERMANY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
19. 6.19 UK MARKET ANALYSIS BY TARGET TISSUE
20. 6.20 UK MARKET ANALYSIS BY NEEDLE SIZE
21. 6.21 UK MARKET ANALYSIS BY MODALITY
22. 6.22 UK MARKET ANALYSIS BY PROCEDURE TYPE
23. 6.23 UK MARKET ANALYSIS BY BIOPSY DEVICE TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY TARGET TISSUE
25. 6.25 FRANCE MARKET ANALYSIS BY NEEDLE SIZE
26. 6.26 FRANCE MARKET ANALYSIS BY MODALITY
27. 6.27 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
28. 6.28 FRANCE MARKET ANALYSIS BY BIOPSY DEVICE TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY TARGET TISSUE
30. 6.30 RUSSIA MARKET ANALYSIS BY NEEDLE SIZE
31. 6.31 RUSSIA MARKET ANALYSIS BY MODALITY
32. 6.32 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
33. 6.33 RUSSIA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
34. 6.34 ITALY MARKET ANALYSIS BY TARGET TISSUE
35. 6.35 ITALY MARKET ANALYSIS BY NEEDLE SIZE
36. 6.36 ITALY MARKET ANALYSIS BY MODALITY
37. 6.37 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
38. 6.38 ITALY MARKET ANALYSIS BY BIOPSY DEVICE TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY TARGET TISSUE
40. 6.40 SPAIN MARKET ANALYSIS BY NEEDLE SIZE
41. 6.41 SPAIN MARKET ANALYSIS BY MODALITY
42. 6.42 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
43. 6.43 SPAIN MARKET ANALYSIS BY BIOPSY DEVICE TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY TARGET TISSUE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY NEEDLE SIZE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY MODALITY
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY BIOPSY DEVICE TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY TARGET TISSUE
51. 6.51 CHINA MARKET ANALYSIS BY NEEDLE SIZE
52. 6.52 CHINA MARKET ANALYSIS BY MODALITY
53. 6.53 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
54. 6.54 CHINA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
55. 6.55 INDIA MARKET ANALYSIS BY TARGET TISSUE
56. 6.56 INDIA MARKET ANALYSIS BY NEEDLE SIZE
57. 6.57 INDIA MARKET ANALYSIS BY MODALITY
58. 6.58 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
59. 6.59 INDIA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY TARGET TISSUE
61. 6.61 JAPAN MARKET ANALYSIS BY NEEDLE SIZE
62. 6.62 JAPAN MARKET ANALYSIS BY MODALITY
63. 6.63 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
64. 6.64 JAPAN MARKET ANALYSIS BY BIOPSY DEVICE TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY TARGET TISSUE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY NEEDLE SIZE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY MODALITY
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY TARGET TISSUE
71. 6.71 MALAYSIA MARKET ANALYSIS BY NEEDLE SIZE
72. 6.72 MALAYSIA MARKET ANALYSIS BY MODALITY
73. 6.73 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
74. 6.74 MALAYSIA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY TARGET TISSUE
76. 6.76 THAILAND MARKET ANALYSIS BY NEEDLE SIZE
77. 6.77 THAILAND MARKET ANALYSIS BY MODALITY
78. 6.78 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
79. 6.79 THAILAND MARKET ANALYSIS BY BIOPSY DEVICE TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY TARGET TISSUE
81. 6.81 INDONESIA MARKET ANALYSIS BY NEEDLE SIZE
82. 6.82 INDONESIA MARKET ANALYSIS BY MODALITY
83. 6.83 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
84. 6.84 INDONESIA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY TARGET TISSUE
86. 6.86 REST OF APAC MARKET ANALYSIS BY NEEDLE SIZE
87. 6.87 REST OF APAC MARKET ANALYSIS BY MODALITY
88. 6.88 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
89. 6.89 REST OF APAC MARKET ANALYSIS BY BIOPSY DEVICE TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY TARGET TISSUE
92. 6.92 BRAZIL MARKET ANALYSIS BY NEEDLE SIZE
93. 6.93 BRAZIL MARKET ANALYSIS BY MODALITY
94. 6.94 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
95. 6.95 BRAZIL MARKET ANALYSIS BY BIOPSY DEVICE TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY TARGET TISSUE
97. 6.97 MEXICO MARKET ANALYSIS BY NEEDLE SIZE
98. 6.98 MEXICO MARKET ANALYSIS BY MODALITY
99. 6.99 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
100. 6.100 MEXICO MARKET ANALYSIS BY BIOPSY DEVICE TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY TARGET TISSUE
102. 6.102 ARGENTINA MARKET ANALYSIS BY NEEDLE SIZE
103. 6.103 ARGENTINA MARKET ANALYSIS BY MODALITY
104. 6.104 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
105. 6.105 ARGENTINA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET TISSUE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEEDLE SIZE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODALITY
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TARGET TISSUE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY NEEDLE SIZE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY MODALITY
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY BIOPSY DEVICE TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TARGET TISSUE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY NEEDLE SIZE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY MODALITY
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY TARGET TISSUE
123. 6.123 REST OF MEA MARKET ANALYSIS BY NEEDLE SIZE
124. 6.124 REST OF MEA MARKET ANALYSIS BY MODALITY
125. 6.125 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
126. 6.126 REST OF MEA MARKET ANALYSIS BY BIOPSY DEVICE TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY TARGET TISSUE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY TARGET TISSUE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY NEEDLE SIZE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY NEEDLE SIZE, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY MODALITY, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY MODALITY, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY BIOPSY DEVICE TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY BIOPSY DEVICE TYPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.2.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.2.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.2.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.2.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.3.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.3.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.3.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.3.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.4.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.4.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.4.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.4.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.5.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.5.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.5.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.5.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.6.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.6.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.6.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.6.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.7.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.7.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.7.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.7.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.8.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.8.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.8.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.8.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.9.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.9.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.9.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.9.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.10.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.10.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.10.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.10.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.11.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.11.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.11.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.11.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.12.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.12.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.12.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.12.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.13.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.13.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.13.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.13.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.14.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.14.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.14.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.14.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.15.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.15.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.15.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.15.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.16.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.16.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.16.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.16.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.17.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.17.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.17.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.17.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.18.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.18.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.18.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.18.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.19.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.19.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.19.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.19.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.20.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.20.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.20.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.20.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.21.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.21.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.21.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.21.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.22.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.22.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.22.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.22.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.23.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.23.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.23.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.23.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.24.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.24.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.24.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.24.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.25.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.25.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.25.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.25.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.26.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.26.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.26.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.26.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.27.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.27.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.27.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.27.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.28.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.28.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.28.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.28.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.29.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.29.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.29.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.29.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TARGET TISSUE, 2025-2035 (USD Billion)
  2. 7.30.2 BY NEEDLE SIZE, 2025-2035 (USD Billion)
  3. 7.30.3 BY MODALITY, 2025-2035 (USD Billion)
  4. 7.30.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  5. 7.30.5 BY BIOPSY DEVICE TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Target Tissue (USD Billion, 2025-2035)

Breast
Prostate
Lung
Liver
Kidney

Healthcare By Needle Size (USD Billion, 2025-2035)

14-Gauge
16-Gauge
18-Gauge
20-Gauge
22-Gauge

Healthcare By Modality (USD Billion, 2025-2035)

Ultrasound-Guided
Stereotactic
Other

Healthcare By Procedure Type (USD Billion, 2025-2035)

Outpatient
Inpatient

Healthcare By Biopsy Device Type (USD Billion, 2025-2035)

Vacuum-Assisted
Spring-Loaded
Gravity-Fed

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓